|
|
Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
|
1R37CA225791-01
|
$358,389
|
$358,389
|
ALJITAWI, OMAR
|
UNIVERSITY OF ROCHESTER
|
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$165,276
|
Alter, Blanche
|
DCEG (NCI)
|
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$755,862
|
$151,172
|
Anderson, Stephen
|
CCR (NCI)
|
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$437,122
|
$43,712
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$374,676
|
$374,676
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
$1,037,400
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$2,485
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$1,715
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$33,345
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$4,987
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
T cell receptor proximal signaling
|
ZIA BC 011715
|
$596,931
|
$298,465
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
$44,524
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-18
|
$672,442
|
$221,906
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-40
|
$250,143
|
$100,057
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
T cell Development and Regeneration
|
ZIA BC 011633
|
$1,139,421
|
$1,139,421
|
Bhandoola, Avinash
|
CCR (NCI)
|
|
|
Metabolic basis of chronic graft-versus-host disease
|
ZIA BC 011725
|
$32,855
|
$32,855
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
|
In vivo cell kinetics and imaging of chronic graft-versus-host-disease
|
ZIA BC 011727
|
$32,855
|
$32,855
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
|
Chronic graft-versus-host disease in children and young adults
|
ZID BC 011729
|
$10,952
|
$7,666
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
5R01CA184728-05
|
$353,419
|
$353,419
|
CAO, XUEFANG
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$820,830
|
$82,083
|
Carrington, Mary
|
CCR (NCI)
|
|
|
Intervention of Immune Tolerance by Small Molecules
|
5R01CA127483-11
|
$311,223
|
$311,223
|
CHEN, SHU-HSIA
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
$184,863
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Clinical Scholars Biomedical Research Training Program
|
5T32CA009512-30
|
$394,664
|
$39,466
|
CHI, PING
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,365,668
|
$409,700
|
Chinquee, Joseph
|
CCR (NCI)
|
|
|
Chronic graft-versus-host disease
|
ZIA BC 011549
|
$888,058
|
$587,669
|
Cowen, Edward
|
CCR (NCI)
|
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$9,978
|
$2,495
|
Cowen, Edward
|
CCR (NCI)
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
$8,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S3
|
$125,000
|
$5,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
$90,649
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$1,458
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$4,009
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$4,680
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$51,480
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
5P01CA142106-14
|
$1,630,446
|
$1,532,619
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-34
|
$666,666
|
$166,667
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
3R44CA221513-02S1
|
$4,319
|
$4,319
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
5R44CA221513-02
|
$982,509
|
$982,509
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-05
|
$721,537
|
$721,537
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$830
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-05
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
|
Investigating the role of interleukin-22 in thymus function
|
5R00CA176376-04
|
$245,184
|
$122,592
|
DUDAKOV, JARROD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-05
|
$161,608
|
$161,608
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
$138,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
|
5R01CA182947-05
|
$319,738
|
$319,738
|
FARAG, SHERIF
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$406
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$62,685
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Cancer Center Support Grant 2018-2023
|
2P30CA046592-29
|
$6,681,232
|
$133,625
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Cancer Center Support Grant 2018-2023
|
3P30CA046592-29S1
|
$60,000
|
$1,200
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Total relevant funding to Bone Marrow Transplantation for this search: $45,396,205
|
